top of page

Page Title

Below are articles on recent, high-impact research, free for your use. If you've enjoyed these and would like access to more resources, consider becoming a member or donating! 

recent articles from high-impact journals 

Simons Foundation Spectrum Newsletter
 
APRIL 2022

Qin, Y., Du, Y., Chen, L. et al. A recurrent SHANK1 mutation implicated in autism spectrum disorder causes autistic-like core behaviors in mice via downregulation of mGluR1-IP3R1-calcium signaling. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01539-1


Abu-Akel, A., Wood, S.J., Upthegrove, R. et al. Psychosocial functioning in the balance between autism and psychosis: evidence from three populations. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01543-5

​

Brynge, M., Gardner, R., Sjöqvist, H. et al. Maternal levels of acute phase proteins in early pregnancy and risk of autism spectrum disorders in offspring. Transl Psychiatry 12, 148 (2022). https://doi.org/10.1038/s41398-022-01907-z


Lee, N.R., Niu, X., Zhang, F. et al. Variegation of autism related traits across seven neurogenetic disorders. Transl Psychiatry 12, 149 (2022). https://doi.org/10.1038/s41398-022-01895-0

MARCH 2022

Liu, D., Nanclares, C., Simbriger, K. et al. Autistic-like behavior and cerebellar dysfunction in Bmal1 mutant mice ameliorated by mTORC1 inhibition. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01499-6

 

Rapanelli, M., Williams, J.B., Ma, K. et al. Targeting histone demethylase LSD1 for treatment of deficits in autism mouse models. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01508-8

 

Yu, H., Cao, R., Lin, C. et al. Distinct neurocognitive bases for social trait judgments of faces in autism spectrum disorder. Transl Psychiatry 12, 104 (2022). https://doi.org/10.1038/s41398-022-01870-9

 

Caubit, X., Gubellini, P., Roubertoux, P.L. et al. Targeted Tshz3 deletion in corticostriatal circuit components segregates core autistic behaviors. Transl Psychiatry 12, 106 (2022). https://doi.org/10.1038/s41398-022-01865-6

 

Straub, L., Bateman, B. T., Hernandez-Diaz, S., York, C., Lester, B., Wisner, K. L., ... & Huybrechts, K. F. (2022). Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States. JAMA psychiatry.


Birnbaum, R., Mahjani, B., Loos, R. J., & Sharp, A. J. (2022). Clinical Characterization of Copy Number Variants Associated With Neurodevelopmental Disorders in a Large-scale Multiancestry Biobank. JAMA psychiatry.

February 2022

Andrews, D. S., Aksman, L., Kerns, C. M., Lee, J. K., Winder-Patel, B. M., Harvey, D. J., ... & Amaral, D. G. (2022). Association of Amygdala Development with Different Forms of Anxiety in Autism Spectrum Disorder. Biological Psychiatry.

 

Huang, Q., Pereira, A. C., Velthuis, H., Wong, N. M., Ellis, C. L., Ponteduro, F. M., ... & McAlonan, G. M. (2022). GABAB receptor modulation of visual sensory processing in adults with and without autism spectrum disorder. Science translational medicine, 14(626), eabg7859.

 

Mazziotti, R., Scaffei, E., Conti, E. et al. The amplitude of fNIRS hemodynamic response in the visual cortex unmasks autistic traits in typically developing children. Transl Psychiatry12, 53 (2022). https://doi.org/10.1038/s41398-022-01820-5

 

Montobbio, N., Cavallo, A., Albergo, D., Ansuini, C., Battaglia, F., Podda, J., ... & Becchio, C. (2022). Intersecting kinematic encoding and readout of intention in autism. Proceedings of the National Academy of Sciences, 119(5).

 

Paulsen, B., Velasco, S., Kedaigle, A. J., Pigoni, M., Quadrato, G., Deo, A. J., ... & Arlotta, P. (2022). Autism genes converge on asynchronous development of shared neuron classes. Nature, 1-6.

 

Sha, Z., van Rooij, D., Anagnostou, E. et al. Subtly altered topological asymmetry of brain structural covariance networks in autism spectrum disorder across 43 datasets from the ENIGMA consortium. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01452-7

Stewart Campbell, A., Needham, B.D., Meyer, C.R. et al. Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial. Nat Med (2022). https://doi.org/10.1038/s41591-022-01683-9

December 2021

Lord, C., Charman, T., Havdahl, A., Carbone, P., Anagnostou, E., Boyd, B., ... & McCauley, J. B. (2021). The Lancet Commission on the future of care and clinical research in autism. The Lancet.

Please note that the Bay Area Autism Consortium provides resource information only. The BAAC cannot recommend any specific clinical treatment and does not specifically endorse any of the listed programs, providers, therapies, medications, or philosophies you may encounter on this site.

bottom of page